Video

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

Anthony El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, discusses recent combination data in hepatocellular carcinoma.

Anthony El-Khoueiry, MD, associate professor of clinical medicine, Keck School of Medicine, USC Norris Comprehensive Cancer Center, discusses recent combination data in hepatocellular carcinoma (HCC).

There was a lot of discussion surrounding early trials in HCC during the 2018 International Liver Cancer Association Annual Conference, says El-Khoueiry. This includes some trials looking at combination therapy. Most of these trials are looking at anti—PD-1/PD-L1 agents with either tyrosine kinase inhibitors (TKIs) such as sorafenib (Nexavar) and lenvatinib (Lenvima), or with anti-VEGF agents.

One of the trials presented at the conference was the combination of atezolizumab (Tecentriq) with bevacizumab (Avastin). Although it showed a response rate of 60%, it was in a small number of patients, so El-Khoueiry says that this should be interpreted with caution. Further data is awaited. Nonetheless, there is excitement for the possibility for combinations of anti—PD-1/PD-L1 agents with anti-VEGF or TKIs in general, El-Khoueiry concludes.

Related Videos
Funda Meric-Bernstam, MD
Laurence Albigès, MD, PhD
Nirav Shah, MD, MSHP, discusses evaluating zamtocabtagene autoleucel in patients with relapsed/refractory diffuse large B-cell lymphoma.
Bhagirathbhai Dholaria, MBBS
Sairah Ahmed, M.D
Barry W. Goy, MD
Fred Saad, CQ, MD, FRCS, FCAHS, director, Prostate Cancer Research, Montreal Cancer Institute, Centre Hospitalier de l’Université de Montréal; full professor, Department of Surgery, Université de Montréal; uro-oncologist, Urology Department, University of Montreal Health Center
Manmeet Singh Ahluwalia, MD, MBA, FASCO, chief scientific officer, chief, medical oncology, deputy director, Fernandez Family Endowed Chair in Cancer Research, Baptist Health Miami Cancer Institute
Kelly E. McCann, MD, PhD, assistant professor, breast medical oncologist, UCLA
Neeta Somaiah, MD